Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Lidocaine × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Colorectal Neoplasms 11 Colonic Neoplasms 4 Pain, Postoperative 3 Liver Neoplasms 3 Stomach Neoplasms 2 Agnosia 2 Recurrence 1 Rectal Neoplasms 1 Patient Satisfaction 1 Pancreatic Neoplasms 1 Pain 1 Neuropathy, Painful 1 Neuralgia 1 Inflammatory Bowel Diseases 1 Ileus 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Diverticulitis 1 Constipation 1 Cold Hypersensitivity 1 Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 10 Gemcitabine 7 Cisplatin 7 Hepatectomy 6 Fluorouracil 6 Radiofrequency Ablation 5 Liver Transplantation 5 Irinotecan 5 Capecitabine 5 Paclitaxel 4 Neoadjuvant Therapy 4 Folfox protocol 4 Cetuximab 4 Aspirin 4 tislelizumab 3 lenvatinib 3 Surgical Procedures, Operative 3 Nivolumab 3 Carboplatin 3 titanium silicide 2 apatinib 2 Trastuzumab 2 S 1 (combination) 2 Leucovorin 2 Lamivudine 2 Ethiodized Oil 2 Drug Therapy 2 DNA, Mitochondrial 2 Chemotherapy, Adjuvant 2 Albumin-Bound Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05250791 2023-06-09

FLICOR

Imperial College London

Phase NA Unknown

Gastrointestinal

Recurrence, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡